Steroids, APACHE II Score, and the Outcome of Abdominal Infection

Archives of Surgery

Volumn 129, Issue 1, 1994, Pages 33-38

  Bohnen, John M A ^a   Mustard, Robert A ^a   Schouten, B Diana ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CORTICOSTEROID; GLUCOCORTICOID; PREDNISONE;

ABDOMINAL INFECTION; ADULT; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM DISEASE; COLLAGEN DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENTERITIS; HUMAN; INFECTION RISK; LUNG DISEASE; MAJOR CLINICAL STUDY; MORTALITY; MYCOSIS; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM;

ABDOMEN; ADULT; COMPARATIVE STUDY; GLUCOCORTICOIDS; GLUCOCORTICOIDS, SYNTHETIC; HOSPITAL MORTALITY; HUMAN; INFECTION; ONTARIO; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0028031901     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1994.01420250045005     Document Type: Article

References (24)

1. Solomkin JS, Dellinger EP, Christou NV, Mason AD. Design and conduct of antibiotic trials: a report of the Scientific Studies Committee of the Surgical Infection Society. Arch Surg. 1987;122:158-164.
2. Nystrom P-O, Bax R, Dellinger EP, et al. Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intra-abdominal infection. World J Surg. 1990;14:148-158.
3. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
4. Bohnen JMA, Mustard RA, Oxholm SE, Schouten BD. APACHE II score and abdominal sepsis: a prospective study. Arch Surg. 1988;123:225-229.
5. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1:54-77.
6. DeMaria EJ, Reichman W, Kenney PR, Armitage JM, Gann DS. Septic complications of corticosteroid administration after central nervous system trauma. Ann Surg. 1985;202:248-252.
7. Dayton MT, Kleckner SC, Brown DK. Peptic ulcer perforation associated with steroid use. Arch Surg. 1987;122:376-380.
8. Rubin RH, Cosimi AB. Infection in the immunocompromised host. In: Howard RJ, Simmons RL, eds. Surgical Infectious Diseases. 2nd ed. East Norwalk, Conn: Appleton & Lange: 1988;849-872.
9. Reding R, Michel LA, Donckier J, de Canniere L, Jamart J. Surgery in patients on long-term steroid therapy: a tentative model for risk assessment. Br J Surg. 1990;77:1175-1178.
10. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg. 1976; 184:333-340.
11. Sleeman HK, Diggs JW, Hayes DK, Hamit HF. Value of antibiotics, corticosteroids, and peritoneal lavage in the treatment of experimental peritonitis. Surgery. 1969;66:1060-1066.
12. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317:653-658.
13. Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med. 1987;317:659-665.
14. Dawson JL. A study of some factors affecting the mortality rate in diffuse peritonitis. Gut. 1963;4:368-372.
15. Stephen M, Loewenthal J. Generalized infective peritonitis. Surg Gynecol Obstet. 1978;147:231-234.
16. Elebute EA, Stoner HB. The grading of sepsis. Br J Surg. 1983;70:29-31.
17. Stevens LE. Gauging the severity of surgical sepsis. Arch Surg. 1983;118: 1190-1192.
18. Meakins JL, Solomkin JS, Allo MD, Dellinger EP, Howard RJ, Simmons RL. A proposed classification of intra-abdominal infections: stratification of etiology and risk for future therapeutic trials. Arch Surg. 1984;119:1372-1378.
19. Dominioni L, Dionigi R, Zanello M, et al. Sepsis score and acute phase protein response as predictors of outcome in septic surgical patients. Arch Surg. 1987; 122:141-146.
20. Dellinger EP. Use of scoring systems to assess patients with surgical sepsis. Surg Clin North Am. 1988;68:123-145.
21. Solomkin JS, Dellinger EP, Christou NV, Busuttil RW. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intraabdominal infections. Ann Surg. 1990;212:581-591.
22. Burchard KW. Fungal sepsis. Infect Dis Clin North Am. 1992;6:677-692.
23. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of Candida in intraperitoneal infections. Surgery. 1980;88:524-530.
24. Peoples JB. Candida and perforated peptic ulcers. Surgery. 1986;100:758-764.